XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands		Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Investments at cost		$ 754,814		$ 721,248
Investments at fair value		729,053		720,026
Biotechnology Sector [Member]
Investments at cost		158,953		193,372
Investments at fair value		139,935		195,006
Medical Device Sector [Member]
Investments at cost		140,172		132,803
Investments at fair value		139,039		135,960
Communications Sector [Member]
Investments at cost		21,057		22,892
Investments at fair value		24,317		26,176
Software Sector [Member]
Investments at cost		164,903		120,157
Investments at fair value		161,258		118,716
Other Sustainability Sector [Member]
Investments at cost		89,395		84,633
Investments at fair value		83,476		85,524
Diagnostics Sector [Member]
Investments at cost		9,971		9,851
Investments at fair value		9,939		9,858
Other Healthcare Sector [Member]
Investments at cost		102		7,559
Investments at fair value		1,379		3,870
Data Storage Sector [Member]
Investments at cost		417		476
Investments at fair value		1,070		1,316
Internet and Media Sector [Member]
Investments at cost		329		329
Investments at fair value		1,615		1,159
Networking Sector [Member]
Investments at cost		6,671		11,831
Investments at fair value		6,558		11,710
Power Management Sector [Member]
Investments at cost		1,585		1,585
Investments at fair value		2,901		2,610
Semiconductor Sector [Member]
Investments at cost		56		56
Investments at fair value		0		0
Software, Healthcare Information and Service [Member]
Investments at cost		50,847		13,735
Investments at fair value		50,971		14,044
Evelo Biosciences, Inc. [Member]
Investments at fair value		8,500
Investment, Unaffiliated Issuer [Member]
Investments at cost		700,932		721,248
Investments at fair value		695,423		720,026
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost		676,864		701,074
Investments at fair value		663,399		686,458
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member]
Investments at cost		7,211		4,184
Investments at fair value		4,735		2,556
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost		15,657		14,790
Investments at fair value		26,189		29,712
Investment, Unaffiliated Issuer [Member] | Other Long-Term Investments [Member]
Investments at cost		1,200		1,200
Investments at fair value		1,100		1,300
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Debt Securities [Member]
Investments at cost		88,394
Investments at fair value		82,643
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Warrant [Member]
Investments at cost		1,001
Investments at fair value		$ 833
Number of Shares (in shares)
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member]
Ceiling
Investments at cost		$ 282,962		268,468
Investments at fair value		278,989		259,366
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member]
Investments at cost		9,744		9,249
Investments at fair value		16,313		16,148
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Debt Securities [Member]
Investments at cost		245,317		318,172
Investments at fair value		241,576		317,568
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Warrant [Member]
Investments at cost				4,197
Investments at fair value				$ 9,792
Number of Shares (in shares)
Investment, Unaffiliated Issuer [Member] | Healthcare Sector [Member] | Debt Securities [Member]
Investments at cost		60,191		$ 30,729
Investments at fair value		60,191		25,819
Investment, Unaffiliated Issuer [Member] | Healthcare Sector [Member] | Warrant [Member]
Investments at cost		729		416
Investments at fair value		2,098		1,953
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member]
Investments at cost		4,183
Investments at fair value		$ 6,945
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member]
Investments at cost				83,705
Investments at fair value				83,705
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member]
Investments at cost				928
Investments at fair value				$ 1,819
Number of Shares (in shares)
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,903		4,891
Investments at fair value		$ 4,903		$ 4,891
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,975		4,963
Investments at fair value		4,975		4,963
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		214		214
Investments at fair value		$ 348		$ 335
Number of Shares (in shares)		7,404		7,404
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Common Stock [Member]
Investments at cost		$ 250		$ 250
Investments at fair value		$ 250		$ 250
Number of Shares (in shares)		1,162		1,162
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,000		$ 3,000
Investments at cost		2,985		2,978
Investments at fair value		$ 2,985		$ 2,978
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,975		4,963
Investments at fair value		$ 4,975		$ 4,963
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,975		4,963
Investments at fair value		$ 4,975		$ 4,963
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		13.25%		12.50%
Margin		4.75%		6.05%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,000		$ 3,000
Investments at cost		2,985		2,978
Investments at fair value		$ 2,985		$ 2,978
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,468		3,360
Investments at fair value		$ 1,749		$ 3,360
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,468		3,460
Investments at fair value		1,749		3,460
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		16		16
Investments at fair value		$ 0		$ 16
Number of Shares (in shares)		86,066		86,066
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.50%		13.00%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 6,875		$ 7,500
Investments at cost		6,840		7,455
Investments at fair value		$ 6,840		$ 7,455
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.50%		13.00%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 6,875		$ 7,500
Investments at cost		6,840		7,455
Investments at fair value		6,840		7,455
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Common Stock Warrants [Member]
Investments at cost		46		46
Investments at fair value		$ 69		$ 67
Number of Shares (in shares)		1,991		1,991
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.50%		13.00%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 6,875		$ 7,500
Investments at cost		6,840		7,455
Investments at fair value		6,840		$ 7,455
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Convertible Debt Securities [Member]
Cash Rate				3.00%
Maturity Date				Jul. 01, 2023
Principal Amount				$ 250
Investments at cost				250
Investments at fair value				$ 306
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Technology Sector [Member] | Preferred Stock [Member]
Investments at cost		261
Investments at fair value		$ 306
Number of Shares (in shares)		1,810
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.00%		14.00%
Margin		6.50%		6.50%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 6,550		$ 6,500
Investments at cost		6,432		6,347
Investments at fair value		$ 6,377		$ 6,347
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.00%		14.00%
Margin		6.50%		6.50%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 6,046		$ 6,000
Investments at cost		5,937		5,859
Investments at fair value		5,886		5,859
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Common Stock Warrants [Member]
Investments at cost		455		455
Investments at fair value		$ 54		$ 197
Number of Shares (in shares)		516,732		516,732
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		15.00%		14.00%
Margin		6.50%		6.50%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 2,519		$ 2,500
Investments at cost		2,472		2,436
Investments at fair value		2,451		$ 2,436
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 10,000
Investments at cost				9,872
Investments at fair value				$ 9,872
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 15,000
Investments at cost				14,808
Investments at fair value				14,808
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost				126
Investments at fair value				$ 125
Number of Shares (in shares)				463,915
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 6,000
Investments at cost				5,923
Investments at fair value				$ 5,923
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 6,000
Investments at cost				5,923
Investments at fair value				$ 5,923
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 4,000
Investments at cost				3,949
Investments at fair value				$ 3,949
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				11.75%
Margin				4.75%
Floor				11.00%
Ceiling				0.00%
ETP				4.25%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 4,000
Investments at cost				3,949
Investments at fair value				$ 3,949
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				1.85%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,951
Investments at fair value				$ 3,834
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				1.85%
Maturity Date				Oct. 01, 2025
Principal Amount				$ 2,500
Investments at cost				2,474
Investments at fair value				1,916
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost				26
Investments at fair value				$ 0
Number of Shares (in shares)				10,690
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 2,885
Investments at cost				2,853
Investments at fair value				$ 2,777
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 2,885
Investments at cost				2,823
Investments at fair value				2,750
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		311		311
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		26,444		26,442
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 1,442
Investments at cost				1,411
Investments at fair value				$ 1,374
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Feb. 01, 2025
Principal Amount				$ 2,885
Investments at cost				2,821
Investments at fair value				$ 2,748
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Feb. 01, 2025
Principal Amount				$ 2,885
Investments at cost				2,821
Investments at fair value				$ 2,748
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Apr. 01, 2025
Principal Amount				$ 1,442
Investments at cost				1,408
Investments at fair value				$ 1,371
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Apr. 01, 2025
Principal Amount				$ 1,442
Investments at cost				1,408
Investments at fair value				$ 1,371
Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.25%
Margin				5.25%
Floor				8.50%
Ceiling				0.00%
ETP				20.00%
Maturity Date				Sep. 15, 2022
Principal Amount				$ 2,500
Investments at cost				2,500
Investments at fair value				$ 2,500
Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.25%
Margin				5.25%
Floor				8.50%
Ceiling				0.00%
ETP				20.00%
Maturity Date				Sep. 15, 2022
Principal Amount				$ 2,500
Investments at cost				2,500
Investments at fair value				$ 2,500
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,605		3,478
Investments at fair value		$ 3,605		$ 3,478
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 1,250		$ 1,250
Investments at cost		1,241		1,238
Investments at fair value		1,241		1,238
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		92		56
Investments at fair value		$ 279		$ 233
Number of Shares (in shares)		37,294		31,966
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,723		3,715
Investments at fair value		$ 3,723		$ 3,715
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 1,250		$ 1,250
Investments at cost		1,241		1,238
Investments at fair value		$ 1,241		$ 1,238
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,723		3,715
Investments at fair value		$ 3,723		$ 3,715
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 1,250		$ 1,250
Investments at cost		1,241		1,238
Investments at fair value		$ 1,241		$ 1,238
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jan. 01, 2028		Jan. 01, 2028
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,709		3,698
Investments at fair value		$ 3,709		$ 3,698
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate		11.25%		11.25%
Margin		6.00%		6.00%
Floor		9.50%		9.50%
Ceiling		11.25%		11.25%
ETP		3.00%		3.00%
Maturity Date		Jan. 01, 2028		Jan. 01, 2028
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,703		3,698
Investments at fair value		$ 3,703		$ 3,698
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate		11.25%
Margin		6.00%
Floor		9.50%
Ceiling		11.25%
ETP		3.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,709
Investments at fair value		$ 3,709
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate		11.25%
Margin		6.00%
Floor		9.50%
Ceiling		11.25%
ETP		3.00%
Maturity Date		Jul. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,705
Investments at fair value		$ 3,705
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eleven [Member]
Cash Rate		11.25%
Margin		6.00%
Floor		9.50%
Ceiling		11.25%
ETP		3.00%
Maturity Date		Jul. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,705
Investments at fair value		$ 3,705
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.25%
Margin		6.75%
Floor		10.00%
Ceiling		0.00%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,750
Investments at cost		3,675
Investments at fair value		$ 3,675
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.25%
Margin		6.75%
Floor		10.00%
Ceiling		0.00%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,750
Investments at cost		3,675
Investments at fair value		3,675
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		81
Investments at fair value		$ 81
Number of Shares (in shares)		400,000
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.50%		13.50%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,481		2,385
Investments at fair value		$ 2,481		$ 2,385
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.50%		13.50%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,481		2,473
Investments at fair value		2,481		2,473
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		47		47
Investments at fair value		$ 15		$ 54
Number of Shares (in shares)		171,370		159,893
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.50%		13.50%
Margin		6.00%		6.00%
Floor		9.25%		9.25%
Ceiling		0.00%		0.00%
ETP		3.50%		3.50%
Maturity Date		Jun. 01, 2026		Jun. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,962		4,946
Investments at fair value		$ 4,962		$ 4,946
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.25%		11.75%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Jan. 01, 2027		Jan. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,663		3,597
Investments at fair value		$ 3,663		$ 3,597
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.25%		11.75%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Jan. 01, 2027		Jan. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,718		3,706
Investments at fair value		3,718		3,706
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		59		40
Investments at fair value		$ 230		$ 46
Number of Shares (in shares)		27,036		19,662
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		4,938
Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member]
Investments at cost		41		$ 39
Investments at fair value		$ 59		$ 55
Number of Shares (in shares)		61,359		61,539
Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 102		$ 102
Investments at fair value		$ 1,379		$ 1,370
Number of Shares (in shares)		82,965		82,965
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.59%
Margin		5.09%
Floor		10.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jan. 01, 2024
Principal Amount		$ 750
Investments at cost		739
Investments at fair value		$ 739
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.59%
Margin		5.09%
Floor		10.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jan. 01, 2024
Principal Amount		$ 50
Investments at cost		49
Investments at fair value		49
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		172		$ 153
Investments at fair value		$ 176		$ 150
Number of Shares (in shares)		1,730,746		1,375,727
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.59%
Margin		5.09%
Floor		10.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Mar. 01, 2024
Principal Amount		$ 1,067
Investments at cost		1,052
Investments at fair value		1,052
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, One [Member]
Cash Rate				12.37%
Margin				8.20%
Floor				10.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jan. 01, 2024
Principal Amount				$ 1,625
Investments at cost				1,610
Investments at fair value				$ 1,610
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Two [Member]
Cash Rate				12.37%
Margin				8.20%
Floor				10.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jan. 01, 2024
Principal Amount				$ 108
Investments at cost				107
Investments at fair value				$ 107
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Three [Member]
Cash Rate				12.37%
Margin				8.20%
Floor				10.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Mar. 01, 2024
Principal Amount				$ 2,000
Investments at cost				1,983
Investments at fair value				1,983
Investment, Unaffiliated Issuer [Member] | Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		138		139
Investments at fair value		$ 3,283		$ 3,265
Number of Shares (in shares)		2,936,535		2,936,535
Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.75%		14.75%
Margin		7.25%		7.25%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,470		3,461
Investments at fair value		3,470		3,461
Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		22		20
Investments at fair value		$ 30		$ 61
Number of Shares (in shares)		75,997		17,605
Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.50%		4.50%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,726		3,678
Investments at fair value		$ 3,726		$ 3,678
Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.50%		4.50%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,726		3,718
Investments at fair value		$ 3,726		3,718
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.22%
Margin		4.72%
Floor		9.75%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jun. 01, 2024
Principal Amount		$ 1,979
Investments at cost		1,971
Investments at fair value		$ 1,971
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.22%
Margin		4.72%
Floor		9.75%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jun. 01, 2024
Principal Amount		$ 1,979
Investments at cost		1,972
Investments at fair value		1,972
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		176		176
Investments at fair value		$ 269		$ 263
Number of Shares (in shares)		110,402		110,402
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member]
Investments at cost		$ 355		$ 356
Investments at fair value		$ 356		$ 356
Number of Shares (in shares)		32,831		32,831
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.22%
Margin		4.72%
Floor		9.75%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Nov. 01, 2025
Principal Amount		$ 5,000
Investments at cost		4,943
Investments at fair value		$ 4,943
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, One [Member]
Cash Rate				12.07%
Margin				7.90%
Floor				9.75%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jun. 01, 2024
Principal Amount				$ 1,979
Investments at cost				1,962
Investments at fair value				$ 1,962
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		13.22%
Margin		4.72%
Floor		9.75%
Ceiling		0.00%
ETP		5.00%
Maturity Date		May 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,939
Investments at fair value		4,939
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Two [Member]
Cash Rate				12.07%
Margin				7.90%
Floor				9.75%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jun. 01, 2024
Principal Amount				$ 1,979
Investments at cost				1,963
Investments at fair value				$ 1,963
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Three [Member]
Cash Rate				12.07%
Margin				7.90%
Floor				9.75%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Nov. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,923
Investments at fair value				$ 4,923
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Four [Member]
Cash Rate				12.07%
Margin				7.90%
Floor				9.75%
Ceiling				0.00%
ETP				5.00%
Maturity Date				May 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,912
Investments at fair value				$ 4,912
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member]
Investments at cost		490
Investments at fair value		$ 0
Number of Shares (in shares)		217,726
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		9.50%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 7,000
Investments at cost		6,677
Investments at fair value		$ 6,677
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		9.50%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,459
Investments at fair value		3,459
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		167
Investments at fair value		$ 0
Number of Shares (in shares)		85,066
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		9.50%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,459
Investments at fair value		$ 3,459
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		9.50%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,750
Investments at cost		2,708
Investments at fair value		2,708
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.50%
Margin				5.50%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 7,000
Investments at cost				6,619
Investments at fair value				$ 6,619
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.50%
Margin				5.50%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,448
Investments at fair value				3,448
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Preferred Stock Warrants [Member]
Investments at cost				160
Investments at fair value				$ 170
Number of Shares (in shares)				80,544
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.50%
Margin				5.50%
Floor				9.50%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,448
Investments at fair value				3,448
Investment, Unaffiliated Issuer [Member] | Corvium, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				53
Investments at fair value				$ 0
Number of Shares (in shares)				661,956
Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Communications Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		92		$ 92
Investments at fair value		$ 139		$ 173
Number of Shares (in shares)		598,850		598,850
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Aug. 01, 2025		Aug. 01, 2025
Principal Amount		$ 1,833		$ 2,500
Investments at cost		1,821		2,482
Investments at fair value		$ 1,821		$ 2,482
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Aug. 01, 2025		Aug. 01, 2025
Principal Amount		$ 1,833		$ 2,500
Investments at cost		1,821		2,482
Investments at fair value		1,821		2,482
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		31		30
Investments at fair value		$ 128		$ 125
Number of Shares (in shares)		46,745		46,745
Investment, Unaffiliated Issuer [Member] | Imunon, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 65		$ 66
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		19,671		16,502
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 5,000		$ 2,500
Investments at cost		4,951		2,463
Investments at fair value		$ 4,951		$ 2,463
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 2,500		$ 5,000
Investments at cost		2,475		4,927
Investments at fair value		2,475		4,927
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		214		214
Investments at fair value		$ 371		$ 361
Number of Shares (in shares)		681		681
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,948		4,924
Investments at fair value		$ 4,948		$ 4,924
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,474		2,462
Investments at fair value		$ 2,474		$ 2,462
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		11.75%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		Dec. 01, 2026		Dec. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,926		4,900
Investments at fair value		$ 4,926		$ 4,900
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		11.75%		10.00%
Ceiling		0.00%		0.00%
ETP		2.75%		2.75%
Maturity Date		Dec. 01, 2026		Dec. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,463		2,450
Investments at fair value		$ 2,463		$ 2,450
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 10,000
Investments at cost		9,647
Investments at fair value		$ 9,647
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,921
Investments at fair value		4,921
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		189
Investments at fair value		$ 191
Number of Shares (in shares)		652,250
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,921
Investments at fair value		$ 4,921
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,921
Investments at fair value		4,921
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.75%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,966
Investments at fair value				$ 4,966
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.75%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,966
Investments at fair value				4,966
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		93		93
Investments at fair value		$ 0		$ 64
Number of Shares (in shares)		20,000		20,000
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.75%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Jan. 01, 2025
Principal Amount				$ 3,000
Investments at cost				2,979
Investments at fair value				$ 2,979
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				13.75%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Dec. 01, 2025
Principal Amount				$ 1,000
Investments at cost				976
Investments at fair value				$ 976
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				13.75%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Feb. 01, 2026
Principal Amount				$ 1,000
Investments at cost				977
Investments at fair value				$ 977
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.00%		13.50%
Margin		3.50%		6.50%
Floor		11.75%		9.75%
Ceiling		0.00%		0.00%
ETP		8.00%		8.00%
Maturity Date		Sep. 01, 2027		Jun. 01, 2025
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,295		2,476
Investments at fair value		$ 2,295		$ 2,476
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.00%		13.50%
Margin		3.50%		6.50%
Floor		11.75%		9.75%
Ceiling		0.00%		0.00%
ETP		8.00%		8.00%
Maturity Date		Sep. 01, 2027		Jun. 01, 2025
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,471		2,476
Investments at fair value		2,471		2,476
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		275		98
Investments at fair value		$ 304		$ 123
Number of Shares (in shares)		2,637,043		605,313
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%		13.50%
Margin		3.50%		6.50%
Floor		11.75%		9.75%
Ceiling		0.00%		0.00%
ETP		8.00%		8.00%
Maturity Date		Sep. 01, 2027		Jun. 01, 2025
Principal Amount		$ 5,000		$ 2,500
Investments at cost		4,943		2,476
Investments at fair value		$ 4,943		$ 2,476
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.00%		13.50%
Margin		3.50%		6.50%
Floor		11.75%		9.75%
Ceiling		0.00%		0.00%
ETP		8.00%		8.00%
Maturity Date		Sep. 01, 2027		Apr. 01, 2026
Principal Amount		$ 5,000		$ 2,500
Investments at cost		4,943		2,453
Investments at fair value		$ 4,943		$ 2,453
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				13.50%
Margin				6.50%
Floor				9.75%
Ceiling				0.00%
ETP				8.00%
Maturity Date				May 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,455
Investments at fair value				$ 2,455
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 10,000		$ 10,000
Investments at cost		9,877		9,826
Investments at fair value		$ 9,877		$ 9,826
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 10,000		$ 10,000
Investments at cost		9,877		9,826
Investments at fair value		9,877		9,826
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		273		273
Investments at fair value		$ 124		$ 296
Number of Shares (in shares)		639,918		639,918
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,939		4,913
Investments at fair value		$ 4,939		$ 4,913
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,939		4,913
Investments at fair value		$ 4,939		$ 4,913
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.25%		12.25%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		May 01, 2027		May 01, 2027
Principal Amount		$ 6,250		$ 6,250
Investments at cost		6,193		6,077
Investments at fair value		$ 6,193		$ 6,077
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.25%		12.25%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		May 01, 2027		May 01, 2027
Principal Amount		$ 6,250		$ 6,250
Investments at cost		6,193		6,177
Investments at fair value		6,193		6,177
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		50		51
Investments at fair value		$ 60		$ 60
Number of Shares (in shares)		48,076		48,077
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Apr. 01, 2028		Jun. 01, 2025
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,678		3,697
Investments at fair value		$ 3,678		$ 3,697
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Apr. 01, 2028		Jun. 01, 2025
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,692		3,717
Investments at fair value		3,692		3,717
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		175		126
Investments at fair value		$ 322		$ 268
Number of Shares (in shares)		46,311		35,906
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Apr. 01, 2028		Oct. 01, 2025
Principal Amount		$ 7,500		$ 7,500
Investments at cost		7,374		7,424
Investments at fair value		$ 7,374		$ 7,424
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Apr. 01, 2028		Oct. 01, 2025
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,687		3,712
Investments at fair value		$ 3,687		$ 3,712
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Apr. 01, 2028		Oct. 01, 2025
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,687		3,712
Investments at fair value		3,687		3,712
Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		61
Investments at fair value		$ 346
Number of Shares (in shares)		7,097,792
Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Software, Healthcare Information and Service [Member] | Preferred Stock Warrants [Member]
Investments at cost				60
Investments at fair value				$ 359
Number of Shares (in shares)				7,097,792
Investment, Unaffiliated Issuer [Member] | Embody, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.00%
Margin				6.50%
Floor				9.75%
Ceiling				0.00%
ETP				28.00%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,482
Investments at fair value				2,482
Investment, Unaffiliated Issuer [Member] | Aterian, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member]
Investments at cost		$ 195		195
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		76,923		76,923
Investment, Unaffiliated Issuer [Member] | Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 146		$ 146
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		16,611		252,161
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		11.75%
Margin		3.25%
Floor		11.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,642
Investments at fair value		$ 4,642
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		11.75%
Margin		3.25%
Floor		11.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,912
Investments at fair value		4,912
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		163
Investments at fair value		$ 167
Number of Shares (in shares)		150,353
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Oct. 01, 2024		Oct. 01, 2024
Principal Amount		$ 2,771		$ 3,208
Investments at cost		2,733		3,143
Investments at fair value		$ 2,733		$ 3,143
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Jun. 01, 2025		Jun. 01, 2025
Principal Amount		$ 1,000		$ 1,000
Investments at cost		982		974
Investments at fair value		982		974
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		124		124
Investments at fair value		$ 59		$ 113
Number of Shares (in shares)		317,647		317,647
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.25%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Apr. 01, 2025
Principal Amount				$ 2,500
Investments at cost				2,476
Investments at fair value				$ 2,476
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.25%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 2,500
Investments at cost				2,473
Investments at fair value				2,473
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost				35
Investments at fair value				$ 0
Number of Shares (in shares)				21,120
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.75%		12.75%
Margin		5.25%		5.25%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,716		3,630
Investments at fair value		$ 3,716		$ 3,630
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.75%		12.75%
Margin		5.25%		5.25%
Floor		8.50%		8.50%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,478		2,469
Investments at fair value		2,478		2,469
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		64		64
Investments at fair value		$ 165		$ 162
Number of Shares (in shares)		103,679		103,679
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2025		Jul. 01, 2025
Principal Amount		$ 3,500		$ 5,000
Investments at cost		3,399		4,857
Investments at fair value		$ 3,365		$ 4,857
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Jul. 01, 2025		Jul. 01, 2025
Principal Amount		$ 1,750		$ 2,500
Investments at cost		1,699		2,430
Investments at fair value		1,684		2,430
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost				366
Investments at fair value				$ 0
Number of Shares (in shares)				47,452
Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		68		$ 68
Investments at fair value		$ 1,060		$ 1,069
Number of Shares (in shares)		268,591		268,591
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 10,000		$ 10,000
Investments at cost		9,898		9,701
Investments at fair value		$ 9,898		$ 9,701
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,712		3,697
Investments at fair value		3,712		3,697
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		162		160
Investments at fair value		$ 667		$ 3,024
Number of Shares (in shares)		299,848		299,848
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,712		3,697
Investments at fair value		3,712		$ 3,697
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member]
Investments at fair value		$ 4,934
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.50%		12.00%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,960		4,939
Investments at fair value		$ 4,960		$ 4,939
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.50%		12.00%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,960		4,939
Investments at fair value		4,960		4,939
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		194		194
Investments at fair value		$ 395		$ 385
Number of Shares (in shares)		809,931		809,931
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.50%		12.00%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,956		4,933
Investments at fair value		$ 4,956		$ 4,933
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		13.50%		12.00%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,956		4,933
Investments at fair value		$ 4,956		$ 4,933
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		13.50%		12.50%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Jan. 01, 2027		Jan. 01, 2027
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,934		4,913
Investments at fair value		$ 4,934		$ 4,913
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		13.50%		12.50%
Margin		5.00%		5.00%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Jan. 01, 2027		Jan. 01, 2027
Principal Amount		$ 5,000		$ 5,000
Investments at cost		$ 4,934		4,913
Investments at fair value				$ 4,913
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.50%		12.50%
Margin		5.00%		5.00%
Floor		5.00%		5.00%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2027		Mar. 01, 2027
Principal Amount		$ 2,000		$ 2,000
Investments at cost		1,335		1,082
Investments at fair value		$ 1,335		$ 1,082
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.50%		12.50%
Margin		5.00%		5.00%
Floor		5.00%		5.00%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Mar. 01, 2027		Mar. 01, 2027
Principal Amount		$ 3,000		$ 3,000
Investments at cost		2,003		1,623
Investments at fair value		2,003		1,623
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member]
Investments at cost		2,945		2,947
Investments at fair value		$ 2,676		$ 2,947
Number of Shares (in shares)		1,312,500		1,312,500
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%		11.00%
Margin		3.50%		3.50%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		7.78%		7.78%
Maturity Date		Feb. 01, 2028		Feb. 01, 2028
Principal Amount		$ 2,813		$ 2,813
Investments at cost		2,813		2,813
Investments at fair value		$ 2,813		$ 2,813
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.00%		11.00%
Margin		3.50%		3.50%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		7.78%		7.78%
Maturity Date		Feb. 01, 2028		Feb. 01, 2028
Principal Amount		$ 2,813		$ 2,813
Investments at cost		2,813		2,813
Investments at fair value		$ 2,813		$ 2,813
Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		1.00%		1.00%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,975		4,966
Investments at fair value		$ 4,975		$ 4,966
Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		1.00%		1.00%
Maturity Date		Apr. 01, 2026		Apr. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,487		2,481
Investments at fair value		$ 2,487		$ 2,481
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.00%		14.00%
Margin		6.50%		6.50%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Mar. 01, 2026		Mar. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,965		4,947
Investments at fair value		$ 4,965		$ 4,947
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.00%		14.00%
Margin		6.50%		6.50%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Mar. 01, 2026		Mar. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,483		2,474
Investments at fair value		2,483		2,474
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		32		34
Investments at fair value		$ 43		$ 41
Number of Shares (in shares)		101,308		101,308
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 4,667
Investments at cost		4,594
Investments at fair value		$ 4,594
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 4,667
Investments at cost		4,594
Investments at fair value		4,594
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		487		$ 399
Investments at fair value		$ 205		$ 648
Number of Shares (in shares)		345,327		203,017
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 2,333
Investments at cost		2,286
Investments at fair value		$ 2,286
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, One [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 4,667
Investments at cost				4,597
Investments at fair value				$ 4,597
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 2,333
Investments at cost		2,286
Investments at fair value		$ 2,286
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Two [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 4,667
Investments at cost				4,597
Investments at fair value				$ 4,597
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 2,333
Investments at cost		2,282
Investments at fair value		$ 2,282
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Three [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 2,333
Investments at cost				2,280
Investments at fair value				$ 2,280
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		13.86%
Margin		5.36%
Floor		9.50%
Ceiling		0.00%
ETP		5.50%
Maturity Date		Dec. 01, 2024
Principal Amount		$ 2,333
Investments at cost		2,282
Investments at fair value		2,282
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Four [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 2,333
Investments at cost				2,280
Investments at fair value				$ 2,280
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Five [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 2,333
Investments at cost				2,274
Investments at fair value				$ 2,274
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Six [Member]
Cash Rate				12.67%
Margin				8.50%
Floor				9.50%
Ceiling				0.00%
ETP				5.50%
Maturity Date				Dec. 01, 2024
Principal Amount				$ 2,333
Investments at cost				2,274
Investments at fair value				2,274
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Common Stock [Member]
Investments at cost		2,000		2,000
Investments at fair value		$ 1,700		$ 1,700
Number of Shares (in shares)		392,651		392,651
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Royalty Agreement [Member]
Investments at cost		$ 1,200		$ 1,200
Investments at fair value		$ 1,100		$ 1,100
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,946
Investments at fair value				$ 4,946
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 2,500
Investments at cost				2,473
Investments at fair value				2,473
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost				67
Investments at fair value				$ 0
Number of Shares (in shares)				39,774
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jan. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,947
Investments at fair value				$ 4,947
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				5.00%
Maturity Date				Jan. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,947
Investments at fair value				$ 4,947
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0.00%		0.00%
ETP		6.00%		6.00%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 4,500		$ 5,000
Investments at cost		4,434		4,914
Investments at fair value		$ 4,434		$ 4,914
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0.00%		0.00%
ETP		6.00%		6.00%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 2,250		$ 2,500
Investments at cost		2,217		2,457
Investments at fair value		2,217		2,457
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		264		264
Investments at fair value		$ 127		$ 37
Number of Shares (in shares)		318,181		318,181
Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Royalty Agreement [Member]
Investments at cost		$ 0		$ 0
Investments at fair value		$ 0		$ 200
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.75%		12.25%
Margin		5.25%		5.25%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,464		3,349
Investments at fair value		$ 3,464		$ 3,349
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.75%		12.25%
Margin		5.25%		5.25%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Jul. 01, 2027		Jul. 01, 2027
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,464		3,454
Investments at fair value		3,464		3,454
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		71		71
Investments at fair value		$ 40		$ 83
Number of Shares (in shares)		135,484		135,484
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,453
Investments at fair value		$ 3,453
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9.00%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,453
Investments at fair value		$ 3,453
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.50%		13.00%
Margin		6.00%		6.00%
Floor		14.25%		9.25%
Ceiling		0.00%		0.00%
ETP		4.00%		3.00%
Maturity Date		Nov. 01, 2026		Jul. 01, 2025
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,418		2,396
Investments at fair value		$ 2,350		$ 2,396
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.50%		13.00%
Margin		6.00%		6.00%
Floor		14.25%		12.25%
Ceiling		0.00%		0.00%
ETP		4.00%		3.00%
Maturity Date		Dec. 01, 2026		Dec. 01, 2026
Principal Amount		$ 1,250		$ 1,250
Investments at cost		1,236		1,231
Investments at fair value		1,201		1,231
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		43		40
Investments at fair value		$ 1		$ 44
Number of Shares (in shares)		85,543		80,197
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.50%
Margin		6.00%
Floor		14.25%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Apr. 01, 2027
Principal Amount		$ 1,000
Investments at cost		993
Investments at fair value		$ 966
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		12.25%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,226
Investments at fair value		$ 2,226
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		12.25%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,455
Investments at fair value		2,455
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		194
Investments at fair value		$ 194
Number of Shares (in shares)		1,600,002
Investment, Unaffiliated Issuer [Member] | vTv Therapeutics Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 44		$ 44
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		95,293		95,293
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.50%
Margin				6.50%
Floor				9.75%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Jan. 01, 2026
Principal Amount				$ 3,210
Investments at cost				3,151
Investments at fair value				$ 0
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.50%
Margin				6.50%
Floor				9.75%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Jan. 01, 2026
Principal Amount				$ 2,963
Investments at cost				2,886
Investments at fair value				0
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost				103
Investments at fair value				$ 0
Number of Shares (in shares)				553,710
Investment, Unaffiliated Issuer [Member] | Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 72		$ 72
Investments at fair value		$ 17		$ 3
Number of Shares (in shares)		126,000		126,000
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 4,000		$ 5,000
Investments at cost		3,975		4,954
Investments at fair value		$ 3,975		$ 4,954
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.25%		14.25%
Margin		6.75%		6.75%
Floor		10.00%		10.00%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 2,000		$ 2,500
Investments at cost		1,987		2,477
Investments at fair value		1,987		2,477
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		29		29
Investments at fair value		$ 63		$ 37
Number of Shares (in shares)		250		143
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,774
Investments at fair value		$ 4,774
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,910
Investments at fair value		4,910
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member]
Investments at cost		223
Investments at fair value		$ 223
Number of Shares (in shares)		948,275
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,910
Investments at fair value		$ 4,910
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.75%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,910
Investments at fair value		4,910
Investment, Unaffiliated Issuer [Member] | AccuVein Inc [Member] | Medical Device Sector [Member] | Common Stock Warrants [Member]
Investments at cost		24		$ 24
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		1,175		1,175
Investment, Unaffiliated Issuer [Member] | Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		11.00%		10.00%
Margin		2.50%		6.75%
Floor		8.00%		10.00%
Ceiling		0.00%		0.00%
ETP		0.00%		0.00%
Maturity Date		Sep. 01, 2027		Sep. 01, 2027
Principal Amount		$ 2,598		$ 2,500
Investments at cost		2,589		2,588
Investments at fair value		$ 2,351		$ 2,279
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 5,547		$ 5,000
Investments at cost		5,505		4,943
Investments at fair value		$ 4,894		$ 4,715
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 2,219		$ 2,000
Investments at cost		2,204		1,981
Investments at fair value		1,960		1,890
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost				197
Investments at fair value				$ 17
Number of Shares (in shares)				1,261,253
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Preferred and Common Stock [Member]
Investments at cost		197
Investments at fair value		$ 0
Number of Shares (in shares)		1,237,370
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 2,774		$ 2,500
Investments at cost		2,759		2,477
Investments at fair value		$ 2,453		$ 2,363
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 3,328		$ 3,000
Investments at cost		3,310		2,971
Investments at fair value		$ 2,943		$ 2,835
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 2,774		$ 2,500
Investments at cost		2,747		2,459
Investments at fair value		$ 2,443		$ 2,345
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 2,774		$ 2,500
Investments at cost		2,747		2,459
Investments at fair value		$ 2,443		$ 2,345
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 5,547		$ 5,000
Investments at cost		5,493		4,914
Investments at fair value		$ 4,884		$ 4,688
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate		14.25%		12.75%
Margin		5.75%		5.75%
Floor		9.00%		9.00%
Ceiling		0.00%		0.00%
ETP		5.25%		2.00%
Maturity Date		Oct. 31, 2023		Dec. 30, 2022
Principal Amount		$ 2,774		$ 2,500
Investments at cost		2,746		2,456
Investments at fair value		2,441		2,342
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Technology Sector [Member] | Preferred Stock [Member]
Investments at cost		89
Investments at fair value		$ 89
Number of Shares (in shares)		2,688,971
Investment, Unaffiliated Issuer [Member] | Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 66		64
Investments at fair value		$ 1,210		$ 1,200
Number of Shares (in shares)		1,818,183		1,818,183
Investment, Unaffiliated Issuer [Member] | CZV, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member]
Investments at cost		$ 81
Investments at fair value		$ 81
Number of Shares (in shares)		65,569
Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Consumer-related Technologies [Member] | Common Stock [Member]
Investments at cost		$ 253		$ 253
Investments at fair value		$ 30		$ 57
Number of Shares (in shares)		87,082		87,082
Investment, Unaffiliated Issuer [Member] | Rocket Pharmaceuticals Corporation [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member]
Investments at cost				$ 17
Investments at fair value				$ 14
Number of Shares (in shares)				7,051
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Aug. 01, 2027		Aug. 01, 2027
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,408		2,347
Investments at fair value		$ 2,408		2,347
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.50%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Jul. 01, 2028
Principal Amount		$ 1,875
Investments at cost		1,783
Investments at fair value		1,783
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		182		104
Investments at fair value		$ 182		$ 104
Number of Shares (in shares)		11,550		6,600
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				6.00%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,463
Investments at fair value				$ 2,364
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.75%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				6.00%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,463
Investments at fair value				2,364
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 48		48
Investments at fair value		$ 10		$ 31
Number of Shares (in shares)		8,800		27,330
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index One [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,466
Investments at fair value		$ 2,344
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index Two [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,466
Investments at fair value		$ 2,344
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index Three [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Jun. 30, 2024
Principal Amount		$ 200
Investments at cost		200
Investments at fair value		$ 190
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.75%		14.25%
Margin		7.25%		7.25%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 1,700		$ 2,700
Investments at cost		1,683		2,673
Investments at fair value		$ 1,683		$ 2,673
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.75%		14.25%
Margin		7.25%		7.25%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Mar. 01, 2025		Mar. 01, 2025
Principal Amount		$ 1,700		$ 2,700
Investments at cost		1,683		2,673
Investments at fair value		1,683		2,673
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		57		57
Investments at fair value		$ 596		$ 429
Number of Shares (in shares)		553,778		553,778
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		15.75%		14.25%
Margin		7.25%		7.25%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Sep. 01, 2025		Sep. 01, 2025
Principal Amount		$ 2,300		$ 3,000
Investments at cost		2,277		2,967
Investments at fair value		2,277		$ 2,967
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.75%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				7.00%
Maturity Date				Nov. 01, 2024
Principal Amount				$ 2,500
Investments at cost				2,475
Investments at fair value				$ 2,475
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.75%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				7.00%
Maturity Date				Nov. 01, 2024
Principal Amount				$ 2,500
Investments at cost				2,489
Investments at fair value				2,489
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		86		84
Investments at fair value		$ 1,307		$ 1,864
Number of Shares (in shares)		12,153		12,153
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.75%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				7.00%
Maturity Date				Nov. 01, 2024
Principal Amount				$ 2,500
Investments at cost				2,473
Investments at fair value				2,473
Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Common Stock [Member]
Investments at cost		$ 9		8
Investments at fair value		$ 83		$ 83
Number of Shares (in shares)		82,974		82,974
Investment, Unaffiliated Issuer [Member] | Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 325		$ 325
Investments at fair value		$ 538		$ 534
Number of Shares (in shares)		6,191		6,191
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Sep. 01, 2025		Sep. 01, 2025
Principal Amount		$ 8,102		$ 7,500
Investments at cost		8,009		7,371
Investments at fair value		$ 6,754		$ 7,371
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Sep. 01, 2025		Sep. 01, 2025
Principal Amount		$ 8,102		$ 7,500
Investments at cost		8,009		7,371
Investments at fair value		$ 6,754		7,371
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member]
Investments at cost				488
Investments at fair value				$ 1,061
Number of Shares (in shares)				204,832
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Sep. 01, 2025		Sep. 01, 2025
Principal Amount		$ 8,102		$ 7,500
Investments at cost		8,009		7,371
Investments at fair value		$ 6,754		$ 7,371
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Jul. 01, 2026		Jul. 01, 2026
Principal Amount		$ 5,402		$ 5,000
Investments at cost		5,332		4,903
Investments at fair value		$ 4,496		$ 4,903
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		15.50%		14.50%
Margin		7.00%		7.00%
Floor		10.25%		10.25%
Ceiling		0.00%		0.00%
ETP		2.50%		2.50%
Maturity Date		Jul. 01, 2026		Jul. 01, 2026
Principal Amount		$ 5,402		$ 5,000
Investments at cost		5,332		4,903
Investments at fair value		$ 4,496		$ 4,903
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		15.50%
Margin		7.00%
Floor		10.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Sep. 30, 2023
Principal Amount		$ 707
Investments at cost		707
Investments at fair value		$ 596
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate		15.50%
Margin		7.00%
Floor		10.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Sep. 30, 2023
Principal Amount		$ 564
Investments at cost		564
Investments at fair value		$ 475
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate		15.50%
Margin		7.00%
Floor		10.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Sep. 30, 2023
Principal Amount		$ 281
Investments at cost		281
Investments at fair value		$ 237
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate		15.50%
Margin		7.00%
Floor		10.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Sep. 30, 2023
Principal Amount		$ 279
Investments at cost		279
Investments at fair value		$ 235
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate		15.50%
Margin		7.00%
Floor		10.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Sep. 30, 2023
Principal Amount		$ 167
Investments at cost		167
Investments at fair value		$ 141
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.50%
Margin		5.00%
Floor		12.00%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 10,000
Investments at cost		9,814
Investments at fair value		$ 9,814
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.50%
Margin		5.00%
Floor		12.00%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		4,938
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		115
Investments at fair value		$ 79
Number of Shares (in shares)		84,037
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.50%
Margin		5.00%
Floor		12.00%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,939
Investments at fair value		$ 4,939
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,751
Investments at fair value		$ 4,751
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,451
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		152
Investments at fair value		$ 152
Number of Shares (in shares)		93,336
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,451
Investments at fair value		$ 2,451
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		16.25%		15.25%
Margin		7.75%		7.75%
Floor		11.00%		11.00%
Ceiling		0.00%		0.00%
ETP		0.00%		0.00%
Maturity Date		May 01, 2027		Jul. 01, 2025
Principal Amount		$ 1,108		$ 2,500
Investments at cost		1,086		2,473
Investments at fair value		$ 872		$ 2,473
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		16.25%		15.25%
Margin		7.75%		7.75%
Floor		11.00%		11.00%
Ceiling		0.00%		0.00%
ETP		0.00%		0.00%
Maturity Date		May 01, 2027		Jul. 01, 2025
Principal Amount		$ 554		$ 1,250
Investments at cost		543		1,236
Investments at fair value		436		1,236
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member]
Investments at cost		32		32
Investments at fair value		$ 0		$ 22
Number of Shares (in shares)		171,081		171,081
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		16.25%		15.25%
Margin		7.75%		7.75%
Floor		11.00%		11.00%
Ceiling		0.00%		0.00%
ETP		0.00%		0.00%
Maturity Date		May 01, 2027		Jul. 01, 2025
Principal Amount		$ 554		$ 1,250
Investments at cost		543		1,236
Investments at fair value		$ 436		$ 1,236
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.00%		10.50%
Margin		3.50%		3.50%
Floor		8.25%		8.25%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Oct. 01, 2024		Oct. 01, 2024
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,985		4,973
Investments at fair value		$ 4,985		$ 4,973
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.00%		10.50%
Margin		3.50%		3.50%
Floor		8.25%		8.25%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Oct. 01, 2024		Oct. 01, 2024
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,985		4,973
Investments at fair value		4,985		4,973
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		69		69
Investments at fair value		$ 213		$ 209
Number of Shares (in shares)		145,483		145,483
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.00%		10.50%
Margin		3.50%		3.50%
Floor		8.25%		8.25%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Oct. 01, 2024		Oct. 01, 2024
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,488		2,478
Investments at fair value		$ 2,488		$ 2,478
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.00%		10.50%
Margin		3.50%		3.50%
Floor		8.25%		8.25%
Ceiling		0.00%		0.00%
ETP		5.50%		5.50%
Maturity Date		Oct. 01, 2024		Oct. 01, 2024
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,488		2,478
Investments at fair value		2,488		2,478
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Common Stock [Member]
Investments at cost		111
Investments at fair value		$ 36
Number of Shares (in shares)		5,205
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Preferred Stock [Member]
Investments at cost				8
Investments at fair value				$ 27
Number of Shares (in shares)				22,313
Investment, Unaffiliated Issuer [Member] | Updater, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member]
Investments at cost		$ 34		$ 34
Investments at fair value		$ 0		$ 42
Number of Shares (in shares)		108,333		108,333
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0.00%		0.00%
ETP		6.00%		6.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 4,722		$ 2,500
Investments at cost		4,678		2,466
Investments at fair value		$ 4,678		$ 2,466
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%		13.00%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0.00%		0.00%
ETP		6.00%		6.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 2,361		$ 5,000
Investments at cost		2,339		4,932
Investments at fair value		2,339		4,932
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		148		148
Investments at fair value		$ 184		$ 179
Number of Shares (in shares)		4,106,174		775,000
Investment, Unaffiliated Issuer [Member] | Branded Online, Inc [Member] | Software Sector [Member] | Common Stock [Member]
Investments at cost		$ 1,079		$ 1,079
Investments at fair value		$ 3		$ 83
Number of Shares (in shares)		5,398		108,004
Investment, Unaffiliated Issuer [Member] | CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 242		$ 242
Investments at fair value		$ 917		$ 909
Number of Shares (in shares)		500,000		500,000
Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		15.75%		14.25%
Margin		7.25%		7.25%
Floor		10.50%		10.50%
Ceiling		0.00%		0.00%
ETP		3.00%		3.00%
Maturity Date		Aug. 01, 2025		Aug. 01, 2025
Principal Amount		$ 3,833		$ 5,000
Investments at cost		3,785		4,932
Investments at fair value		3,785		4,932
Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		56		56
Investments at fair value		$ 48		$ 39
Number of Shares (in shares)		3,731		3,731
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		13.32%
Margin		4.82%
Floor		9.25%
Ceiling		0.00%
ETP		10.36%
Maturity Date		Jul. 01, 2025
Principal Amount		$ 3,960
Investments at cost		3,916
Investments at fair value		3,916
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		218		$ 221
Investments at fair value		$ 236		$ 226
Number of Shares (in shares)		7,972,222		7,972,222
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, One [Member]
Cash Rate				12.17%
Margin				8.00%
Floor				9.25%
Ceiling				0.00%
ETP				10.36%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 3,960
Investments at cost				3,898
Investments at fair value				$ 3,898
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Two [Member]
Cash Rate				12.17%
Margin				8.00%
Floor				9.25%
Ceiling				0.00%
ETP				10.36%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 3,960
Investments at cost				3,898
Investments at fair value				$ 3,898
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				16.93%
Margin				9.43%
Floor				12.68%
Ceiling				0.00%
ETP				50.43%
Maturity Date				Dec. 31, 2022
Principal Amount				$ 3,295
Investments at cost				3,295
Investments at fair value				3,295
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member]
Investments at cost				46
Investments at fair value				$ 0
Number of Shares (in shares)				82,967
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Equity Securities [Member]
Investments at cost				$ 230
Investments at fair value				$ 0
Number of Shares (in shares)				72,638,663
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Preferred Stock [Member]
Investments at cost		$ 2,800
Investments at fair value		$ 1,281
Number of Shares (in shares)		280,000
Investment, Unaffiliated Issuer [Member] | Silk, Inc [Member] | Data Storage Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 175		$ 234
Investments at fair value		$ 153		$ 407
Number of Shares (in shares)		394,110		442,110
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,952		4,870
Investments at fair value		$ 4,952		$ 4,870
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,952		4,933
Investments at fair value		4,952		4,933
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		123		123
Investments at fair value		$ 135		$ 133
Number of Shares (in shares)		309,208		309,208
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,952		4,933
Investments at fair value		$ 4,952		$ 4,933
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.25%		13.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0.00%		0.00%
ETP		5.00%		5.00%
Maturity Date		Aug. 01, 2026		Aug. 01, 2026
Principal Amount		$ 5,000		$ 5,000
Investments at cost		4,952		4,933
Investments at fair value		4,952		4,933
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		18		22
Investments at fair value		$ 44		$ 312
Number of Shares (in shares)		71,305		288,115
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Preferred Stock [Member]
Investments at cost		$ 4
Investments at fair value		$ 193
Number of Shares (in shares)		66,127
Investment, Unaffiliated Issuer [Member] | Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 75		$ 75
Investments at fair value		$ 63		$ 0
Number of Shares (in shares)		245,810		245,810
Investment, Unaffiliated Issuer [Member] | CVRx, Inc [Member] | Medical Device Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 76		$ 76
Investments at fair value		$ 272		$ 394
Number of Shares (in shares)		47,410		47,410
Investment, Unaffiliated Issuer [Member] | Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 92		$ 92
Investments at fair value		$ 336		$ 357
Number of Shares (in shares)		261,721		261,721
Investment, Unaffiliated Issuer [Member] | Skillshare, Inc [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 162		$ 162
Investments at fair value		$ 1,216		$ 802
Number of Shares (in shares)		139,074		139,074
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.50%
Ceiling		0.00%
ETP		4.00%
Maturity Date		Sep. 01, 2024
Principal Amount		$ 917
Investments at cost		887
Investments at fair value		$ 887
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Sep. 01, 2024		Sep. 01, 2024
Principal Amount		$ 1,833		$ 3,333
Investments at cost		1,807		3,286
Investments at fair value		$ 1,807		$ 3,286
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Sep. 01, 2024		Sep. 01, 2024
Principal Amount		$ 1,833		$ 3,333
Investments at cost		1,807		3,286
Investments at fair value		1,807		3,286
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		364		364
Investments at fair value		$ 251		$ 243
Number of Shares (in shares)		344,102		344,102
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Sep. 01, 2024		Sep. 01, 2024
Principal Amount		$ 917		$ 1,667
Investments at cost		903		1,641
Investments at fair value		$ 903		$ 1,641
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.75%		13.25%
Margin		6.25%		6.25%
Floor		9.50%		9.50%
Ceiling		0.00%		0.00%
ETP		4.00%		4.00%
Maturity Date		Sep. 01, 2024		Sep. 01, 2024
Principal Amount		$ 917		$ 1,667
Investments at cost		903		1,641
Investments at fair value		$ 903		$ 1,641
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				13.25%
Margin				6.25%
Floor				9.50%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 1,667
Investments at cost				1,613
Investments at fair value				$ 1,613
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.75%		13.50%
Margin		4.25%		6.50%
Floor		12.00%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		4.00%
Maturity Date		Jun. 01, 2028		Feb. 01, 2025
Principal Amount		$ 2,500		$ 3,500
Investments at cost		2,457		3,472
Investments at fair value		$ 2,457		$ 3,472
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.75%		13.50%
Margin		4.25%		6.50%
Floor		12.00%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		4.00%
Maturity Date		Jun. 01, 2028		Feb. 01, 2025
Principal Amount		$ 3,500		$ 3,500
Investments at cost		3,489		3,472
Investments at fair value		3,489		$ 3,472
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		64
Investments at fair value		$ 146
Number of Shares (in shares)		682
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.75%		13.50%
Margin		4.25%		6.50%
Floor		12.00%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		4.00%
Maturity Date		Jun. 01, 2028		Dec. 01, 2025
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,492		2,472
Investments at fair value		$ 2,492		$ 2,472
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.75%		13.50%
Margin		4.25%		6.50%
Floor		12.00%		9.75%
Ceiling		0.00%		0.00%
ETP		2.50%		4.00%
Maturity Date		Jun. 01, 2028		Dec. 01, 2025
Principal Amount		$ 1,500		$ 2,500
Investments at cost		1,495		2,472
Investments at fair value		1,495		2,472
Investment, Unaffiliated Issuer [Member] | Meditrina, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		83		83
Investments at fair value		$ 104		$ 101
Number of Shares (in shares)		233,993		233,993
Investment, Unaffiliated Issuer [Member] | Halio, Inc [Member] | Power Management Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 1,585		$ 1,585
Investments at fair value		$ 2,901		$ 2,610
Number of Shares (in shares)		5,002,574		5,002,574
Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Preferred and Common Stock [Member]
Investments at cost		$ 56
Investments at fair value		$ 0
Number of Shares (in shares)		6,081
Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Warrant [Member]
Investments at cost				$ 56
Investments at fair value				$ 0
Number of Shares (in shares)				6,081
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.25%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 3,750
Investments at cost				3,699
Investments at fair value				$ 3,699
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.25%
Margin				6.75%
Floor				10.00%
Ceiling				0.00%
ETP				3.00%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 3,750
Investments at cost				3,699
Investments at fair value				3,699
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				61
Investments at fair value				$ 74
Number of Shares (in shares)				201,537
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.00%		13.75%
Margin		5.50%		6.75%
Floor		14.00%		10.00%
Ceiling		0.00%		0.00%
ETP		3.00%		5.00%
Maturity Date		Oct. 01, 2028		Mar. 01, 2026
Principal Amount		$ 5,000		$ 2,500
Investments at cost		4,857		2,421
Investments at fair value		$ 4,857		$ 2,421
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.00%		13.75%
Margin		5.50%		6.75%
Floor		14.00%		10.00%
Ceiling		0.00%		0.00%
ETP		3.00%		5.00%
Maturity Date		Oct. 01, 2028		Mar. 01, 2026
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,464		2,487
Investments at fair value		2,464		2,487
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		98		21
Investments at fair value		$ 147		$ 69
Number of Shares (in shares)		161,215		77,828
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		14.00%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		$ 2,464
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		14.00%
Margin		5.50%
Floor		14.00%
Ceiling		0.00%
ETP		3.00%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		$ 2,464
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.50%
Margin		4.00%
Floor		11.75%
Ceiling		0.00%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,768
Investments at fair value		$ 4,768
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.50%
Margin		4.00%
Floor		11.75%
Ceiling		0.00%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		2,464
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		120
Investments at fair value		$ 122
Number of Shares (in shares)		345,443
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.50%
Margin		4.00%
Floor		11.75%
Ceiling		0.00%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		2,464
Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		53		$ 53
Investments at fair value		$ 1		$ 1
Number of Shares (in shares)		408		408
Investment, Unaffiliated Issuer [Member] | E La Carte, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member]
Investments at cost		$ 60		$ 60
Investments at fair value		$ 0		$ 3
Number of Shares (in shares)		147,361		147,361
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.00%
Margin				5.50%
Floor				11.00%
Ceiling				18.00%
ETP				3.00%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,798
Investments at fair value				$ 4,798
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.00%
Margin				5.50%
Floor				11.00%
Ceiling				18.00%
ETP				3.00%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,948
Investments at fair value				4,948
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				6
Investments at fair value				$ 6
Number of Shares (in shares)				86,300
Investment, Unaffiliated Issuer [Member] | Everstream Holdings, LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 70
Investments at fair value		$ 71
Number of Shares (in shares)		350,000
Investment, Unaffiliated Issuer [Member] | Revinate Holdings, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 44		$ 46
Investments at fair value		$ 103		$ 99
Number of Shares (in shares)		682,034		682,034
Investment, Unaffiliated Issuer [Member] | Riv Data Corp [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 12
Investments at fair value				$ 296
Number of Shares (in shares)				321,428
Investment, Unaffiliated Issuer [Member] | SIGNiX, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 225		$ 225
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		186,235		186,235
Investment, Unaffiliated Issuer [Member] | Skyword, Inc [Member] | Software Sector [Member] | Warrant [Member]
Investments at cost				$ 48
Investments at fair value				$ 1
Number of Shares (in shares)				301,055
Investment, Unaffiliated Issuer [Member] | Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 64
Investments at fair value				$ 83
Number of Shares (in shares)				682
Investment, Unaffiliated Issuer [Member] | Topia Mobility, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 138		$ 138
Investments at fair value		$ 0		$ 0
Number of Shares (in shares)		3,049,607		3,049,607
Investment, Unaffiliated Issuer [Member] | xAd, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost		$ 177		$ 177
Investments at fair value		$ 12		$ 12
Number of Shares (in shares)		4,343,348		4,343,348
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Oct. 01, 2025
Principal Amount				$ 4,943
Investments at cost				4,943
Investments at fair value				$ 1,668
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.25%
Margin				5.75%
Floor				9.00%
Ceiling				0.00%
ETP				4.00%
Maturity Date				Dec. 31, 2025
Principal Amount				$ 2,500
Investments at cost				2,467
Investments at fair value				832
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Preferred Stock Warrants [Member]
Investments at cost				47
Investments at fair value				$ 0
Number of Shares (in shares)				77,690
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost		$ 39,666		$ 0
Investments at fair value		20,485	$ 906	0	$ 0	$ 0	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
Investments at cost		34,540
Investments at fair value		12,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost		126
Investments at fair value		0
Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member] | Equity Securities [Member]
Investments at cost		5,000
Investments at fair value		$ 8,485
Number of Shares (in shares)
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 7,778
Investments at cost		7,672
Investments at fair value		$ 2,666
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 11,667
Investments at cost		11,509
Investments at fair value		3,997
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member]
Investments at cost		5,000
Investments at fair value		$ 8,485
Number of Shares (in shares)		2,164,502
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 4,681
Investments at cost		4,618
Investments at fair value		$ 1,604
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 4,667
Investments at cost		4,603
Investments at fair value		$ 1,597
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 3,111
Investments at cost		3,069
Investments at fair value		1,068
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Warrant [Member]
Investments at cost		126
Investments at fair value		$ 0
Number of Shares (in shares)		23,196
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		11.00%
Ceiling		0.00%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 3,111
Investments at cost		3,069
Investments at fair value		1,068
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments at fair value		0	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] | Medical Device Sector [Member] | Common Stock [Member]
Investments at cost		0
Investments at fair value		$ 0
Number of Shares (in shares)		660,537
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments at fair value	[1]	$ 0	906	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member]
Investments at cost		0
Investments at fair value		$ 408
Number of Shares (in shares)		600,000
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost		$ 14,216		0
Investments at fair value		13,145	0	0	$ 0	$ 0	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Biotechnology Sector [Member] | Other Investments [Member]
Investments at cost		6,154
Investments at fair value		6,154
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Debt Securities [Member]
Investments at cost		5,251
Investments at fair value		4,439
Investment, Affiliated Issuer, Controlled [Member] | Technology Sector [Member] | Equity Securities [Member]
Investments at cost		2,811
Investments at fair value		$ 2,552
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.00%
Ceiling		0.00%
ETP		2.78%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 3,604
Investments at cost		3,556
Investments at fair value		$ 3,006
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.00%
Ceiling		0.00%
ETP		2.78%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 1,719
Investments at cost		1,695
Investments at fair value		1,433
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Preferred and Common Stock [Member]
Investments at cost		2,811
Investments at fair value		$ 2,552
Number of Shares (in shares)		2,551,596
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments at fair value		$ 6,154	$ 0	$ 0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Biotechnology Sector [Member] | Other Investments [Member]
Investments at cost		6,154
Investments at fair value		$ 6,154
[1] As of September 30, 2023, the Company no longer owns 5% or more of the portfolio company.

X

- Definition

The ceiling rate of the investment owned.

+ References

No definition available.

+ Details

Name:	hrzn_InvestmentOwnedCeilingRate
Namespace Prefix:	hrzn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The end of term payment rate (ETP) on investment owned.

+ References

No definition available.

+ Details

Name:	hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix:	hrzn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Percentage added to reference rate used to compute variable rate on investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Minimum rate of interest on investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentInterestRateFloor
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Rate of interest paid in cash on investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Maturity date of investment, in YYYY-MM-DD format.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentMaturityDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Cost of the investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19

+ Details

Name:	us-gaap_InvestmentOwnedAtCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Fair value of investment in security owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-2

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(2)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(2)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of principal of investment owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Number of shares of investment owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_ConvertibleDebtSecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CorinthMedtechIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CorviumIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EmbodyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_FstarTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexSixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ImvIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_VtvTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_InteriorDefineIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_PreferredAndCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RocketPharmaceuticalsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsInc1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BrandedOnlineIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CvrxIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GroundspeedAnalyticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RivDataCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SkywordIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SecureTransfusionServicesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: